Lab business > Distributorships & acquisitions

TTP Labtech acquires fluorescence lifetime technology

13 January, 2014

TTP Labtech has consolidated its position in the field of fluorescence lifetime (FLT) technology, having recently purchased assets from UK-based FLT company AssayMetrics.


Admedus acquires manufacturing facility from Genzyme Australasia

13 December, 2013

Healthcare group Admedus (formerly Allied Healthcare) has signed a share purchase agreement to acquire an established manufacturing site from Genzyme Australasia, a Sanofi company. Admedus purchased the site to facilitate scaled-up production of its regenerative tissue product CardioCel.


Merck Biopharm osteoarthritis co-research agreement

22 November, 2013

Biopharm and Merck Serono have entered a joint discovery project focusing on a potential pro-anabolic osteoarthritis modifying drug based on a growth factor derived from the Biopharm growth factor platform technology.


LabGear appointed as distributor for Grant and Planer

29 October, 2013

LabGear Australia has been appointed as a distributor for Grant Instruments and the exclusive distributor in Australia and New Zealand for Planer. Both companies are based in the UK.


Sartorius to acquire TAP Biosystems

08 October, 2013

Laboratory and pharmaceutical equipment provider Sartorius Stedim Biotech has made a cash offer to acquire UK company TAP Biosystems through its wholly owned subsidiary, Sartorius Stedim Biotech GmbH.


Seal Analytical acquires Thomas Cain

02 October, 2013

Seal Analytical - a global supplier of automated colorimetric analyser instrumentation - has acquired Thomas Cain. Seal Analytical says the acquisition will enhance its capabilities in the water and soil analysis markets.


AXT to distribute TTP Labtech life science products in A/NZ

13 September, 2013

Analytical and sample preparation equipment supplier ATX has become the exclusive Australian and New Zealand agent for UK-based TTP Labtech's life science product range. TTP Labtech is a developer and manufacturer of products for pharmaceutical and biotech research at both the industrial and academic levels.


Rigaku and Emerald Bio announce strategic alliance in protein crystallography

02 August, 2013

Rigaku, a supplier of X-ray instrumentation and automation equipment for structural biology, has acquired the crystallisation reagent and consumable business, including Wizard screens, from protein science company Emerald Bio.


Trajan completes SGE acquisition

12 July, 2013

Trajan Scientific and Medical has completed its acquisition of the chromatography and liquid handling businesses of SGE Analytical Science.


United Bioresearch appointed Australian distributor for Abiocode

03 May, 2013

United Bioresearch has announced its appointment as the Australian distributor for Californian-based Abiocode.


Qiagen acquires Ingenuity Systems

01 May, 2013

Qiagen has announced the acquisition of Ingenuity Systems, a provider of software solutions that efficiently and accurately analyse and interpret the biological meaning of genomic data.


Scitek now representing LC Technology Solutions

30 April, 2013

LC Technology Solutions has teamed up with Scitek Australia as its exclusive distributor in Australia and New Zealand.


Thermo Fisher Scientific to acquire Life Technologies Corporation

16 April, 2013

Thermo Fisher Scientific and Life Technologies Corporation have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76 in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of net debt at close ($2.2 billion as of year-end 2012).


Applikon Biotechnology acquires biotech portfolio from HaloteC Instruments

04 April, 2013

Bioreactor systems company Applikon Biotechnology has signed a definitive agreement to acquire the biotechnology portfolio of HaloteC Instruments, a Dutch provider of instruments and software solutions for the biotech market.


Lonza and Hyglos reach agreement for Endotoxin detection patents

15 March, 2013

Lonza Walkersville and Hyglos GmbH have reached a mutually beneficial global settlement which includes a licence agreement for Hyglos under certain Lonza patents in the area of endotoxin detection.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd